$0.90
−17.71%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.94
From 52W high−99.39%
Volume1.49M
Market cap$3.27M
P/E (TTM)—
P/S (TTM)0.4x
Div yield—
Key dataSep 18, 2026
Open
$0.94
From 52W high
−99.39%
Volume
1.49M
Market cap
$3.27M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.1x
P/E (TTM)
—
RSI (14)
39.8
MomentumView details →
1D Return
−17.71%
YTD Return
−98.50%
SummaryUpdated Jun 1, 2026
Nuwellis, Inc. (NASDAQ:NUWE) is a medical device company founded in 1999 and headquartered in Eden Prairie, Minnesota. Originally known as CHF Solutions, Inc., the company changed its name to Nuwellis in April 2021. The company specializes in developing, manufacturing, and commercializing medical devices for ultrafiltration therapy, primarily targeting patients with fluid overload conditions who have not responded adequately to traditional diuretic medications. With over two decades of experience in the field, Nuwellis has established itself as a focused player in the specialized medical device market, serving hospitals and clinics both domestically and internationally through direct sales and distributor partnerships.
Similar companies
Latest newsMore news →
Nuwellis reported that 31 Aquadex SmartFlow consoles were sold year-to-date, exceeding full-year console sales in seven of the past 10 years.3d agoNuwellis appointed Brian Johnson as Director of Quality and Regulatory Affairs.4d agoNuwellis entered into a strategic commercial agreement with Atrility Medical to expand its pediatric and critical care portfolio, with a milestone-based pathway to U.S. distribution.26d ago